Jinwon Life Sciences "Subsidiary VGXI Successfully Completes New Factory Employee Family Tour"
[Asia Economy Reporter Jang Hyowon] On the 11th, Jinwon Life Sciences announced that on the 9th, VGXI, a plasmid DNA contract development and manufacturing organization (CDMO) company, invited employees' families to tour the new factory being constructed at Deison Technology Park in Conroe, Texas, USA.
VGXI, a subsidiary of Jinwon Life Sciences, completed the overall exterior construction of the new factory in October last year and has been conducting test operations of a 3000L fermenter for plasmid DNA contract development and manufacturing since the second quarter.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
CEO Park Younggeun said, “Ahead of the completion of the VGXI new factory, about 300 employees' families attended, and the new factory tour event was successfully concluded,” adding, “We are pleased to be able to meet customer demands through differentiated, high-quality plasmid DNA production at the new factory.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
